Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kenvue and Kimberly-Clark are merging in a $32B deal with $2.1B in synergies and major consumer health potential. Learn why KVUE and KMB are rated hold.

Texas officials have asked a state court judge to temporarily block Kenvue Inc. from marketing Tylenol as safe for pregnant ...

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Aid maker Kenvue , even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based ...

Kimberly-Clark will acquire Kenvue, the Johnson & Johnson spinoff, in a $48.7B cash and stock deal to create a global consumer health leader.

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...